CCEL 株価分析 — Cryocell International Inc (Healthcare >> Medical Care Facilities)
CCEL に関するよくある質問
CCELのPER(株価収益率)は?
Cryocell International Inc(CCEL)は現在PER 13.19倍で取引されています。
CCELのROE(自己資本利益率)は?
Cryocell International IncのROEは13.89%です。
CCELの配当利回りは?
Cryocell International Incの配当利回りは0.00%です。
CCELの品質スコア(Quality Score)は?
当社のAIはCCELの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
CCELは今が買い時ですか?
当社AIのタイミングスコアは100点中3点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
CCELはどのセクターに属しますか?
Cryocell International IncはHealthcare >> Medical Care Facilitiesセクターに分類されます(NYSE MKT市場)
CCEL AI Analysis Summary
Our AI summary for CCEL: Cryocell International Inc (NYSE MKT), Healthcare >> Medical Care Facilities sector. The stock currently trades at a P/E of 13.19, ROE of 13.89%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 3/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 3.64
Price
0.08
(2.25%)
Day Change
|
|
|---|
CCEL, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そして テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
39% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 92 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 3.64 |
| PBV / Sector |
-1.65 / 2.75
|
| Earning Per Share | -0.31 |
| PE / Sector |
13.19 / 23.53
|
| PEG or PE/Growth / Sector |
-0.03 / 1.35
|
| Average 1M Daily Value |
0.03 M
GREAT
|
| Average 1W Daily Value |
0.03 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-06 07:59:46 |
| Symbol | CCEL |
| Name | CRYOCELL INTERNATIONAL INC |
| Sector | Healthcare >> Medical Care Facilities |
| Market | NYSE MKT |
| Listed Shares | 8.06 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 29.35 / 7,399.39 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 700 Brooker Creek Boulevard, Oldsmar, FL, United States, 34677
Phone: 813 749 2100
Website: https://www.cryo-cell.com
Employees: 72
Description: Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Care Facilities
Click a bubble to view stock details · Bubble size represents market capitalization share
Google